The Stop ALD Foundation focuses on accelerating the process of developing new knowledge and new therapies for adrenoleukodystrophy (ALD), and works to accelerate implementation of newborn screening for ALD. As well, there is a focus on the adult form of the disease, Adrenomyeloneuropathy (AMN). We also educate the medical profession and the public about ALD/AMN, raising awareness in order to improve detection, diagnosis and treatment. In addition, we serve as a resource to families affected by the condition.
Stop ALD Foundation
representative: Amber Salzman